resveratrol has been researched along with Coronary Artery Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Avila, A; Azzawi, M; Coeckelberghs, E; Cornelissen, V; Degens, H; Diaz, M; Vanhees, L | 1 |
| Bashore, MJ; Brandel, EZ; Creasey, HN; Jones, CM; Nguyen, R | 1 |
| Dávalos, A; Espín, JC; García-Almagro, FJ; García-Conesa, MT; Gil-Zamorano, J; Gonzálvez, M; Larrosa, M; Ruiz Ros, JA; Tomás-Barberán, FA; Tomé-Carneiro, J; Yáñez-Gascón, MJ | 1 |
| Cachia, AJ; Chung, HR; Tomayko, EJ; Wilund, KR | 1 |
| Andrews, KL; Berger, PJ; Chin-Dusting, JP; Horlock, D; Jefferis, AM; Joshi, MS; Kaye, DM; Samarasinghe, T; Williams, D | 1 |
| Netticadan, T; Raj, P; Zieroth, S | 1 |
| Favaloro, EJ; Franchini, M; Lippi, G; Targher, G | 1 |
| Chang, YL; Chen, LK; Chen, SJ; Chen, YC; Hsu, CC; Hwang, SJ; Kao, CL; Ku, HH; Lo, WL; Yung, MC | 1 |
| Chu, LM; Clements, RT; Feng, J; Han, Y; Manning, WJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW | 1 |
| Chu, LM; Lassaletta, AD; Robich, MP; Sellke, FW | 1 |
| Battyany, I; Czopf, L; Feher, G; Fulop, A; Halmosi, R; Magyar, K; Palfi, A; Sumegi, B; Szabados, E; Toth, K | 1 |
| Espín, JC; García-Almagro, FJ; García-Conesa, MT; Gonzálvez, M; Larrosa, M; Ruiz-Ros, JA; Tomás-Barberán, FA; Tomé-Carneiro, J; Yáñez-Gascón, MJ | 1 |
| Das, SK; Oudit, GY; Patel, VB | 1 |
| Mahady, GB; Pendland, SL; Schriever, C | 1 |
3 review(s) available for resveratrol and Coronary Artery Disease
| Article | Year |
|---|---|
An overview of the efficacy of resveratrol in the management of ischemic heart disease.
Topics: Animals; Cardiotonic Agents; Coronary Artery Disease; Genetic Therapy; Humans; Myocardial Reperfusion Injury; Resveratrol; Stilbenes | 2015 |
Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".
Topics: Alcohol Drinking; Antioxidants; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Endothelium, Vascular; Fibrinolysis; Hemostasis; Humans; Resveratrol; Stilbenes; Wine | 2010 |
Resveratrol in the prevention and treatment of coronary artery disease.
Topics: Animals; Cardiovascular System; Coronary Artery Disease; Humans; Lipid Peroxidation; Lipids; Macrophages; Metabolic Syndrome; Muscle, Smooth, Vascular; Myocardial Reperfusion; Plaque, Atherosclerotic; Resveratrol; Stilbenes; Thrombosis; Wine | 2011 |
4 trial(s) available for resveratrol and Coronary Artery Disease
| Article | Year |
|---|---|
Acute resveratrol supplementation in coronary artery disease: towards patient stratification.
Topics: Aged; Biomarkers; Brachial Artery; Cardiac Rehabilitation; Coronary Artery Bypass; Coronary Artery Disease; Cross-Over Studies; Exercise Therapy; Female; Humans; Kinetics; Male; Middle Aged; Oxygen; Oxygen Consumption; Percutaneous Coronary Intervention; Resveratrol; Single-Blind Method; Treatment Outcome; Vasodilation | 2020 |
One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Coronary Artery Disease; Cytokines; Diabetes Mellitus, Type 2; Dietary Supplements; Gene Expression Regulation; Humans; Hypertension; Inflammation; Leukocytes, Mononuclear; Male; MicroRNAs; Middle Aged; Models, Molecular; Plant Extracts; Resveratrol; Stilbenes; Transcriptome; Vitis | 2013 |
Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease.
Topics: Aged; Antioxidants; Brachial Artery; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Erythrocyte Deformability; Female; Humans; Male; Myocardial Infarction; Placebos; Platelet Aggregation; Resveratrol; Stilbenes; Vasodilation; Ventricular Function, Left | 2012 |
Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease.
Topics: Adiponectin; Anti-Inflammatory Agents; Coronary Artery Disease; Dietary Supplements; Down-Regulation; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Plant Extracts; Research Design; Resveratrol; Stilbenes; Transcription Factors; Treatment Outcome; Vitis | 2013 |
7 other study(ies) available for resveratrol and Coronary Artery Disease
| Article | Year |
|---|---|
Covalent attachment of resveratrol to stainless steel toward the development of a resveratrol-releasing bare-metal stent.
Topics: Cell Adhesion; Cell Proliferation; Coated Materials, Biocompatible; Coronary Artery Disease; Delayed-Action Preparations; Drug Liberation; Endothelial Cells; Humans; Nitric Oxide; Oxidative Stress; Resveratrol; Stainless Steel; Stents; Surface Properties; Treatment Outcome; Zirconium | 2020 |
Resveratrol supplementation reduces aortic atherosclerosis and calcification and attenuates loss of aerobic capacity in a mouse model of uremia.
Topics: Animals; Aorta; Calcinosis; Coronary Artery Disease; Dietary Supplements; Disease Models, Animal; Female; Humans; Mice; Oxygen; Resveratrol; Stilbenes; Uremia | 2014 |
Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol.
Topics: Animals; Blood Glucose; Cell Movement; Cell Proliferation; Cells, Cultured; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelial Cells; Humans; Isolated Heart Preparation; Male; Microcirculation; Microvessels; Mitochondria; Myocardial Contraction; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Time Factors; Vasodilation | 2015 |
Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation.
Topics: Animals; Antioxidants; Base Sequence; Cells, Cultured; Cellular Senescence; Coronary Artery Disease; DNA Primers; Endothelial Cells; Gene Knockdown Techniques; Humans; Hydrogen Peroxide; Oxidative Stress; Rats; Resveratrol; RNA, Messenger; RNA, Small Interfering; Sirtuin 1; Stilbenes | 2010 |
Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia.
Topics: Animals; Biomarkers; Cholesterol; Coronary Artery Disease; Diet; Dietary Supplements; Fatty Acids, Nonesterified; Gene Expression Regulation; Glucose Tolerance Test; Glucose Transporter Type 4; Heart; Inflammation; Insulin; Magnetic Resonance Imaging; Metabolic Syndrome; Microvessels; Muscle Cells; Myocardial Ischemia; Oxidation-Reduction; Protein Transport; Resveratrol; Risk Factors; Stilbenes; Swine | 2011 |
Beneficial effects of grape resveratrol on serum adiponectin and inflammation: clinical trial in patients with stable coronary artery disease: editorial to: "Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral
Topics: Adiponectin; Anti-Inflammatory Agents; Coronary Artery Disease; Female; Humans; Leukocytes, Mononuclear; Male; Resveratrol; Stilbenes; Transcription Factors; Vitis | 2013 |
Red wine, resveratrol, Chlamydia pneumoniae and the French connection.
Topics: Azithromycin; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Artery Disease; Female; France; Humans; Male; Microbial Sensitivity Tests; Platelet Aggregation Inhibitors; Primary Prevention; Prognosis; Resveratrol; Risk Assessment; Stilbenes; United States; Wine | 2003 |